Does IBRUTINIB Cause Neoplasm malignant? 305 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 305 reports of Neoplasm malignant have been filed in association with IBRUTINIB (Imbruvica). This represents 0.4% of all adverse event reports for IBRUTINIB.
305
Reports of Neoplasm malignant with IBRUTINIB
0.4%
of all IBRUTINIB reports
61
Deaths
100
Hospitalizations
How Dangerous Is Neoplasm malignant From IBRUTINIB?
Of the 305 reports, 61 (20.0%) resulted in death, 100 (32.8%) required hospitalization, and 3 (1.0%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IBRUTINIB. However, 305 reports have been filed with the FAERS database.
What Other Side Effects Does IBRUTINIB Cause?
Death (8,007)
Off label use (5,446)
Fatigue (4,479)
Diarrhoea (3,903)
Atrial fibrillation (3,671)
Pneumonia (3,015)
Incorrect dose administered (2,752)
Contusion (2,712)
Fall (2,375)
Asthenia (2,200)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which IBRUTINIB Alternatives Have Lower Neoplasm malignant Risk?
IBRUTINIB vs IBUPROFEN
IBRUTINIB vs IBUPROFEN LYSINE
IBRUTINIB vs IBUPROFEN UNKNOWN PRODUCT
IBRUTINIB vs IBUPROFEN\IBUPROFEN
IBRUTINIB vs IBUPROFEN\PHENYLEPHRINE